Scholars Central

ArticlePublished 3 May 2019

3D-QSAR and molecular docking studies of quinazoline derivatives as glycogen synthase kinase-3Ã?ŽÃ?² (Gsk-3Ã?ŽÃ?²) inhibitors

Authors: Srinivas Sangu, Aparna Vema, Rajkamal Bigala

Der Pharmacia Lettre

Volume 6 · Issue 6 · Pages 289–296

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The discovery of glycogen synthase kinase-3β (GSK3β) inhibitors has proven to be challenging task to identify novel and potent gsk3β inhibitors. The quantitative structure activity relationship (QSAR) and docking approach became very useful and largely widespread technique for ligand-based drug design. The computational study deals with development of 3D QSAR models for 85 selected quinazoline derivatives using the stepwise variable selection knearest neighbor molecular field analysis approach; a leave-one-out cross validation method. The developed model showed satisfactory statistical significance r2 (Regression) with 0.75 and q2 (Correlation coefficient) 0.81. Further we have carried out molecular docking studies with the x-ray crystal structure of glycogen synthase kinase domain. These studies showed that quinazoline scaffold can be utilized for designing of novel GSK-3β inhibitors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharmacia Lettre.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharmacia Lettre
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Srinivas Sangu”
  • BylineArticles whose byline prints “Aparna Vema”
  • BylineArticles whose byline prints “Rajkamal Bigala”